Moderna’s omicron-targeted vaccine nearly twice as effective against BA.4, BA.5

As vaccine-makers race to show promising results for their updated, omicron-targeted vaccines set to debut this fall, Moderna forged ahead to prove its candidate is nearly twice as effective as its original vaccine.